المؤلفون: Masaki Ishida, Kenji Morimoto, Tadaaki Yamada, Shinsuke Shiotsu, Yusuke Chihara, Takahiro Yamada, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Shinsaku Tokuda, Takayuki Takeda, Koichi Takayama

المصدر: Thoracic Cancer, Vol 13, Iss 2, Pp 173-181 (2022)

مصطلحات موضوعية: chemoimmunotherapy, docetaxel plus ramucirumab, non‐small‐cell lung cancer, performance status, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1759-7706; https://doaj.org/toc/1759-7714

URL الوصول: https://doaj.org/article/957f69dde99b46e1a7ef430e0b3218f5

المؤلفون: Yoshie Morimoto, Shinsaku Tokuda, Yusuke Chihara, Tadaaki Yamada, Koichi Takayama, Osamu Hiranuma, Masahiro Iwasaku, Kenji Morimoto, Takayuki Takeda, Masaki Ishida, Takahiro Yamada, Shinsuke Shiotsu

المصدر: Thoracic Cancer
Thoracic Cancer, Vol 13, Iss 2, Pp 173-181 (2022)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Adult, Male, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Antineoplastic Agents, Docetaxel, Antibodies, Monoclonal, Humanized, Ramucirumab, Chemoimmunotherapy, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, performance status, Humans, neoplasms, non‐small‐cell lung cancer, RC254-282, Aged, Retrospective Studies, Chemotherapy, Performance status, business.industry, Standard treatment, docetaxel plus ramucirumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, General Medicine, Original Articles, Middle Aged, Chemotherapy regimen, Regimen, chemoimmunotherapy, Original Article, Female, Immunotherapy, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::573c6c1222b794c8205f9cb98556f7f5
http://europepmc.org/articles/PMC8758423